title: A novel analytical method for pharmaceutical polymorphs by terahertz spectroscopy and the optimization of crystal form at the discovery stage.
abstract: A novel analytical method for the determination of pharmaceutical polymorphs was developed using terahertz spectroscopy. It was found out that each polymorph of a substance showed a specific terahertz absorption spectrum. In particular, analysis of the second derivative spectrum was enormously beneficial in the discrimination of closely related polymorphs that were difficult to discern by powder X-ray diffractometry. Crystal forms that were obtained by crystallization from various solvents and stored under various conditions were specifically characterized by the second derivative of each terahertz spectrum. Fractional polymorphic transformation for substances stored under stressed conditions was also identified by terahertz spectroscopy during solid-state stability test, but could not be detected by powder X-ray diffractometry. Since polymorphs could be characterized clearly by terahertz spectroscopy, further physicochemical studies could be conducted in a timely manner. The development form of compound examined was determined by the results of comprehensive physicochemical studies that included thermodynamic relationships, as well as chemical and physicochemical stability. In conclusion, terahertz spectroscopy, which has unique power in the elucidation of molecular interaction within a crystal lattice, can play more important role in physicochemical research. Terahertz spectroscopy has a great potential as a tool for polymorphic determination, particularly since the second derivative of the terahertz spectrum possesses high sensitivity for pharmaceutical polymorphs.
authors.affiliation: Discovery Research Center, Takeda Pharmaceutical Company, Ltd., Osaka, Japan. Ikeda_Yukihiro@takeda.co.jp
authors.forename: Yukihiro
authors.initials: Y
authors.lastname: Ikeda
authors.forename: Yoko
authors.initials: Y
authors.lastname: Ishihara
authors.forename: Toshiya
authors.initials: T
authors.lastname: Moriwaki
authors.forename: Eiji
authors.initials: E
authors.lastname: Kato
authors.forename: Katsuhide
authors.initials: K
authors.lastname: Terada
mesh_terms: D003460:Crystallization; D004304:Dosage Forms; D004355:Drug Stability; D004867:Equipment Design; D055068:Terahertz Spectroscopy / Q000295:instrumentation / Q000379:methods*
chemical_list: D004304:Dosage Forms